SpringWorks Therapeutics Ownership | Who Owns SpringWorks Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

SpringWorks Therapeutics Ownership Summary


SpringWorks Therapeutics is owned by 100.22% institutional investors, 1.28% insiders. Fmr is the largest institutional shareholder, holding 15.02% of SWTX shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 6.48% of its assets in SpringWorks Therapeutics shares.

SWTX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockSpringWorks Therapeutics100.22%1.28%-1.50%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr11.16M15.02%$403.14M
Blackrock funding, inc. /de7.26M9.70%$341.18M
Vanguard group7.16M9.64%$258.65M
Blackrock5.62M7.62%$211.68M
Glazer capital4.11M5.48%$193.04M
Boxer capital3.42M4.64%$128.89M
Price t rowe associates inc /md/3.27M4.41%$118.32M
State street3.09M4.18%$116.28M
Fil3.01M4.02%$141.63M
Tig advisors2.61M3.49%$122.69M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Harvest management687.50K13.75%$32.31M
Trium capital llp787.46K9.21%$37.00M
Chicago capital management200.23K6.91%$9.41M
Glazer capital4.11M6.90%$193.04M
Nexpoint asset management1.58M6.79%$74.39M
Boxer capital3.42M6.79%$128.89M
Kryger capital765.52K6.66%$35.97M
Tig advisors2.61M6.59%$122.69M
First trust capital management1.94M6.18%$91.34M
Water island capital703.52K4.71%$33.06M

Top Buyers

HolderShares% AssetsChange
Glazer capital4.11M6.90%4.11M
Fil3.01M0.12%3.01M
Tig advisors2.61M6.59%2.36M
Magnetar financial2.05M0.47%2.05M
First trust capital management1.94M6.18%1.94M

Top Sellers

HolderShares% AssetsChange
Deep track capital, lp---3.46M
Polar capital---1.75M
Pictet asset management sa9.62K0.00%-1.66M
Ecor1 capital---1.56M
Siren---1.38M

New Positions

HolderShares% AssetsChangeValue
Glazer capital4.11M6.90%4.11M$193.04M
Fil3.01M0.12%3.01M$141.63M
Magnetar financial2.05M0.47%2.05M$96.45M
First trust capital management1.94M6.18%1.94M$91.34M
Nexpoint asset management1.58M6.79%1.58M$74.39M

Sold Out

HolderChange
Capital performance advisors llp-3.00
Riggs asset managment-7.00
Federated hermes-10.00
Parallax volatility advisers-16.00
Stephens consulting-20.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2025246-28.90%75,052,1892.06%1001.04%142-26.04%66-25.84%
Mar 31, 202534754.22%73,495,378-9.12%980.83%19354.40%8934.85%
Dec 31, 2024102-55.46%38,519,465-52.09%510.44%63-51.54%26-56.67%
Sep 30, 20242276.57%80,349,0324.19%1080.99%1292.38%5911.32%
Jun 30, 2024213-6.99%77,114,142-0.98%1040.94%126-11.89%53-3.64%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Growth Compy Commingled Pl O4.81M6.48%13.68K
American Funds SMALLCAP World A2.34M3.15%1.13M
Vanguard Total Stock Mkt Idx Inv2.31M3.07%8.80K
Vanguard US Total Market Shares ETF2.10M2.80%2.02K
iShares Russell 2000 ETF1.83M2.43%-
Polar Capital Biotech S Inc1.75M2.33%250.00K
Vanguard Small Cap Index1.75M2.33%-44.39K
SPDR® S&P Biotech ETF1.39M1.85%-22.76K
Fidelity Growth Company K61.18M1.58%-
Vanguard Institutional Extnd Mkt Idx Tr1.16M1.54%3.90K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 03, 2025Edris Badreddin Chief Operating OfficerSell$22.48K
Mar 03, 2025Edris Badreddin Chief Operating OfficerSell$208.45K
Mar 03, 2025Edris Badreddin Chief Operating OfficerSell$655.33K
Mar 03, 2025Edris Badreddin Chief Operating OfficerSell$198.33K
Mar 03, 2025Islam Saqib Chief Executive OfficerSell$625.02K

Insider Transactions Trends


DateBuySell
2025 Q3--
2025 Q2--
2025 Q1-25
2024 Q4-4
2024 Q3-6

SWTX Ownership FAQ


Who Owns SpringWorks Therapeutics?

SpringWorks Therapeutics shareholders are primarily institutional investors at 100.22%, followed by 1.28% insiders and -1.50% retail investors. The average institutional ownership in SpringWorks Therapeutics's industry, Biotech Stocks , is 306.59%, which SpringWorks Therapeutics falls below.

Who owns the most shares of SpringWorks Therapeutics?

SpringWorks Therapeutics’s largest shareholders are Fmr (11.16M shares, 15.02%), Blackrock funding, inc. /de (7.26M shares, 9.70%), and Vanguard group (7.16M shares, 9.64%). Together, they hold 34.36% of SpringWorks Therapeutics’s total shares outstanding.

Does Blackrock own SpringWorks Therapeutics?

Yes, BlackRock owns 7.62% of SpringWorks Therapeutics, totaling 5.62M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 211.68M$. In the last quarter, BlackRock increased its holdings by 180.4K shares, a 3.32% change.

Who is SpringWorks Therapeutics’s biggest shareholder by percentage of total assets invested?

Harvest management is SpringWorks Therapeutics’s biggest shareholder by percentage of total assets invested, with 13.75% of its assets in 687.5K SpringWorks Therapeutics shares, valued at 32.31M$.

Who is the top mutual fund holder of SpringWorks Therapeutics shares?

Fidelity Growth Compy Commingled Pl O is the top mutual fund holder of SpringWorks Therapeutics shares, with 6.48% of its total shares outstanding invested in 4.81M SpringWorks Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools